Metraipolis › archive › dc_f6df079eaf37

A New Direction in Endometrial Cancer Therapy-PD-1 and PD-L1 Immune Checkpoint Inhibitors-Where Will It Take Us? — Europe PMC PMID:41375669

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41375669
DOI
10.3390/jcm14238366
License (as archived)
solo-consultazione
Archived
2026-11-08T07:06:12.742Z
SHA-256 of the archived text
7995d71dda85ddb76c743feb3a1b1b82c8b35ec4b18594c8ced801a4d0138a4f
Stable URL of this page
https://metraipolis.com/documento/dc_f6df079eaf37

How to cite

A New Direction in Endometrial Cancer Therapy-PD-1 and PD-L1 Immune Checkpoint Inhibitors-Where Will It Take Us? — Europe PMC PMID:41375669 — Europe PMC (en), https://europepmc.org/article/MED/41375669 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f6df079eaf37 (Metraipolis archive dc_f6df079eaf37, sha256 7995d71dda85ddb76c743feb3a1b1b82c8b35ec4b18594c8ced801a4d0138a4f)
BibTeX
@misc{dcf6df079eaf37,
  title = {A New Direction in Endometrial Cancer Therapy-PD-1 and PD-L1 Immune Checkpoint Inhibitors-Where Will It Take Us? — Europe PMC PMID:41375669},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41375669},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f6df079eaf37; sha256 7995d71dda85ddb76c743feb3a1b1b82c8b35ec4b18594c8ced801a4d0138a4f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41375669. Agents can read the archived copy with the MCP tool read_document.